Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

McMaster researchers map toxic protein associated with Alzheimer's

A team of researchers from McMaster University has mapped at atomic resolution a toxic protein linked to Alzheimer's disease, allowing them to better understand what is happening deep within the brain during the earliest stages of the disease.

20 Jun 2019

Study shows risk of sudden death may apply even to people with well-controlled epilepsy

People with epilepsy have a rare risk of sudden death. A new study shows that risk may apply even to people whose epilepsy is well-controlled, which is contrary to previous, smaller studies that showed the risk was highest among those with severe, difficult-to-treat epilepsy.

20 Jun 2019

Sleep patterns can predict Alzheimer’s pathology later in life

Sleep patterns can predict the accumulation of Alzheimer’s pathology proteins later in life, according to a new study of older men and women published in JNeurosci. These findings could lead to new sleep-based early diagnosis and prevention measures in the treatment of Alzheimer’s disease.

From Society for Neuroscience 19 Jun 2019

Researchers propose new model for studying age-related cognitive decline

People are living longer than ever before, but brain health isn't keeping up. To tackle this critical problem, a team of researchers has proposed a new model for studying age-related cognitive decline - one that's tailored to the individual.

18 Jun 2019

Antioxidant protecting the brain linked to deterioration in areas susceptible to Alzheimer's

New research may explain why an antioxidant that protects the brain is also associated with deterioration in areas susceptible to Alzheimer's disease.

18 Jun 2019

Canadian Institutes of Health Research and partners fund CCNA's second phase

Thanks to a $46-million investment from the Canadian Institutes of Health Research (CIHR) and other funding partners, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be renewed for a second phase, announced today.

17 Jun 2019

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.

17 Jun 2019

Scientists create 'mini-brain' for studying sporadic Creutzfeldt-Jakob disease

National Institutes of Health scientists have used human skin cells to create what they believe is the first cerebral organoid system, or "mini-brain," for studying sporadic Creutzfeldt-Jakob disease.

16 Jun 2019

Study shows marked impairment of moral emotions in patients with frontotemporal dementia

A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.

16 Jun 2019

Scientists improve working memory by extending brain signals

Researchers have discovered that short term memory can be improved by artificially extending neuronal signals called sharp wave ripples.

14 Jun 2019

New machine-learning method more precisely quantifies a known indicator for psychosis

A machine-learning method discovered a hidden clue in people's language predictive of the later emergence of psychosis -- the frequent use of words associated with sound.

14 Jun 2019

'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports.

13 Jun 2019

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Apolipoproten E is a major genetic risk factor for the development of Alzheimer's disease, yet the protein tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease.

13 Jun 2019

Researchers develop first blood-brain barrier chip using stem cells

Researchers at Ben-Gurion University of the Negev and Cedars-Sinai Medical Center in Los Angeles have, for the first time, duplicated a patient's blood-brain barrier, creating a human BBB chip with stem cells, which can be used to develop personalized medicine and new techniques to research brain disorders.

13 Jun 2019

Drink containing multinutrient combination can benefit patients with mild cognitive impairment

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect® can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports

13 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Women have better memories of events than men

Memories of events, episodic memory, is better amongst women compared to men, researchers from Karolinska Institutet in Sweden have found in a new overview published in the scientific journal Psychological Bulletin.

12 Jun 2019

New tool seeks to predict postoperative delirium severity in older adults

A new tool seeks to predict the severity of patients' postoperative delirium and help practitioners more effectively care for patients as they recover from surgery.

11 Jun 2019

Early life adversity and high levels of FKBP5 protein amplify anxiety-like behavior

Researchers continue to dig for molecular clues to better understand how gene-environment interactions influence neuropsychiatric disease risk and resilience.

11 Jun 2019

Smarter, more educated people get a cognitive 'head start', but aren't protected from Alzheimer's

In a search for clues to what may delay or prevent Alzheimer's disease, Johns Hopkins Medicine scientists report that smarter, more educated people aren't protected from the disease, but do get a cognitive "head start" that may keep their minds functioning better temporarily.

From Johns Hopkins Medicine 11 Jun 2019

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

McMaster researchers map toxic protein associated with Alzheimer's

Study shows risk of sudden death may apply even to people with well-controlled epilepsy

Sleep patterns can predict Alzheimer’s pathology later in life

Researchers propose new model for studying age-related cognitive decline

Antioxidant protecting the brain linked to deterioration in areas susceptible to Alzheimer's

Canadian Institutes of Health Research and partners fund CCNA's second phase

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Scientists create 'mini-brain' for studying sporadic Creutzfeldt-Jakob disease

Study shows marked impairment of moral emotions in patients with frontotemporal dementia

Scientists improve working memory by extending brain signals

New machine-learning method more precisely quantifies a known indicator for psychosis

'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Researchers develop first blood-brain barrier chip using stem cells

Drink containing multinutrient combination can benefit patients with mild cognitive impairment

Scientists identify potential target for Parkinson's treatment

Women have better memories of events than men

New tool seeks to predict postoperative delirium severity in older adults

Early life adversity and high levels of FKBP5 protein amplify anxiety-like behavior

Smarter, more educated people get a cognitive 'head start', but aren't protected from Alzheimer's

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in